Results 201 to 210 of about 42,523 (291)
Lack of Effect of Single High Doses of Buprenorphine on Arterial Blood Gases in the Rat [PDF]
Papa Guèye+6 more
openalex +1 more source
Toxicological analyses of the bone matrix: Successes and challenges
Abstract This study aimed to conduct an in‐depth and systematic literature review dealing with toxicological analyses on human bone tissue and focusing on the forensic toxicological and archaeotoxicological field. Several studies have focused their research on medical drugs, drugs of abuse, and trace elements on both human cadavers and skeletal remains,
Gaia Giordano+3 more
wiley +1 more source
Less Driving Impairment on Buprenorphine than Methadone in Drug-Dependent Patients? [PDF]
Michael Soyka+3 more
openalex +1 more source
Prognostic factors in bushfire‐affected koalas–Kangaroo Island bushfire response 2020
This study presents a retrospective analysis of clinical records data from koalas presenting for treatment following the large‐scale bushfire event on Kangaroo Island 2019–2020. The aim of the study was to identify prognostic factors for koalas affected by bushfire. Koalas (n = 199) were grouped based on their burn status in combination with their burn
O Funnell+6 more
wiley +1 more source
Effects of Indatraline and Buprenorphine on Self-Administration of Speedball Combinations of Cocaine and Heroin by Rhesus Monkeys [PDF]
Nancy K. Mello, S. Stevens Negus
openalex +1 more source
Abstract Background and Purpose Opioid use disorder (OUD) is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative affective states. Classical antidepressants or the currently prescribed opioid pharmacotherapies have limited efficacy to reverse the negative affect or prevent relapse ...
Andria Michael+7 more
wiley +1 more source
Buprenorphine Substitution Ameliorates Spontaneous Withdrawal in Fentanyl-Dependent Rat Pups [PDF]
Alka B Lohmann, Forrest L. Smith
openalex +1 more source
Abstract Background and Purpose Emerging literature indicates that simultaneously targeting glucagon‐like peptide‐1 receptors (GLP‐1Rs) and neuropeptide Y receptors (Y1/Y2) may represent a new pharmacotherapeutic approach to treating opioid use disorder (OUD).
Antonia Caffrey+5 more
wiley +1 more source
Thrice-weekly versus daily buprenorphine maintenance
Richard S. Schottenfeld+5 more
openalex +1 more source